Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CryoLife Inc (NYSE:CRY)

18.70
Delayed Data
As of Dec 09
 +0.10 / +0.54%
Today’s Change
8.94
Today|||52-Week Range
20.15
+73.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$614.3M

Company Description

CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through Medical Devices and Preservation Services segments. The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, HeRO Graft, and ProCol. The Preservation Services segment offers external services revenues from the preservation of cardiac and vascular tissues. The company was founded by Steven G. Anderson on January 19, 1984 and is headquartered in Kennesaw, GA.

Contact Information

CryoLife, Inc.
1655 Roberts Boulevard NW
Kennesaw Georgia 30144-3632
P:(770) 419-3355
Investor Relations:

Employees

Shareholders

Mutual fund holders35.05%
Other institutional32.15%
Individual stakeholders18.91%

Top Executives

James Patrick MackinChairman, President & Chief Executive Officer
David Ashley LeeChief Operating & Financial Officer, Executive VP
Scott B. CappsVice President-Clinical Research
David C. GaleVice President-Research & Development
Jean F. HollowaySecretary, Chief Compliance Officer & Senior VP